138 related articles for article (PubMed ID: 6676732)
21. Safety and efficacy of long-term diet and diet plus bile acid-binding resin cholesterol-lowering therapy in 73 children heterozygous for familial hypercholesterolemia.
Glueck CJ; Mellies MJ; Dine M; Perry T; Laskarzewski P
Pediatrics; 1986 Aug; 78(2):338-48. PubMed ID: 3526270
[TBL] [Abstract][Full Text] [Related]
22. "Low dose" colestipol in children, adolescents and young adults with familial hypercholesterolemia.
Schlierf G; Mrozik K; Heuck CC; Middelhoff G; Oster P; Riesen W; Schellenberg B
Atherosclerosis; 1982 Jan; 41(1):133-8. PubMed ID: 7073790
[TBL] [Abstract][Full Text] [Related]
23. Pediatric familial type II hyperlipoproteinemia: therapy with diet and colestipol resin.
Glueck CJ; Fallat RW; Mellies M; Tsang RC
Pediatrics; 1976 Jan; 57(1):68-74. PubMed ID: 174057
[TBL] [Abstract][Full Text] [Related]
24. Effect of colestipol and clofibrate on plasma lipid and lipoproteins in type IIa hyperlipoproteinemia.
Hunninghake DB; Probstfield JL; Crow LO; Isaacson SO
Metabolism; 1981 Jun; 30(6):605-9. PubMed ID: 7231197
[TBL] [Abstract][Full Text] [Related]
25. Plasma vitamin A and E levels in children with familial type II hyperlipoproteinemia during therapy with diet and cholestyramine resin.
Glueck CJ; Tsang RC; Fallat RW; Scheel D
Pediatrics; 1974 Jul; 54(1):51-5. PubMed ID: 4365953
[No Abstract] [Full Text] [Related]
26. Comparison of the effects of colestipol hydrochloride and clofibrate on plasma lipids and lipoproteins in the treatment of hypercholesterolemia.
Seplowitz AH; Smith FR; Berns L; Eder HA; Goodman DS
Atherosclerosis; 1981 Apr; 39(1):35-43. PubMed ID: 7018502
[TBL] [Abstract][Full Text] [Related]
27. Effects of colestipol, clofibrate, and placebo on plasma lipoproteins of patients with hypercholesterolemia.
Crouse JR; Grundy SM
Metabolism; 1981 Feb; 30(2):123-8. PubMed ID: 7464561
[TBL] [Abstract][Full Text] [Related]
28. Treatment of hypercholesterolemia.
Grundy SM
Am J Clin Nutr; 1977 Jun; 30(6):985-92. PubMed ID: 326023
[No Abstract] [Full Text] [Related]
29. Drug therapy in children and adolescents with familial hypercholesterolemia.
Stein EA
Prog Clin Biol Res; 1988; 255():273-80. PubMed ID: 3340641
[No Abstract] [Full Text] [Related]
30. Fat-soluble vitamin concentrations in hypercholesterolemic children treated with colestipol.
Schwarz KB; Goldstein PD; Witztum JL; Schonfeld G
Pediatrics; 1980 Feb; 65(2):243-50. PubMed ID: 7354970
[TBL] [Abstract][Full Text] [Related]
31. Effect of colestipol and clofibrate, singly and in combination, on plasma lipid and lipoproteins in type IIb hyperlipoproteinemia.
Hunninghake DB; Bell C; Olson L
Metabolism; 1981 Jun; 30(6):610-5. PubMed ID: 7231198
[TBL] [Abstract][Full Text] [Related]
32. Hypertriglyceridemia: a relative contraindication to the use of bile acid-binding resins?
Denke MA; Grundy SM
Hepatology; 1988; 8(4):974-5. PubMed ID: 3391527
[No Abstract] [Full Text] [Related]
33. Colestipol in familial type II hyperlipoproteinemia: a three-year trial.
Harvengt C; Desager JP
Clin Pharmacol Ther; 1976 Sep; 20(3):310-4. PubMed ID: 182429
[TBL] [Abstract][Full Text] [Related]
34. Pathogenesis and management of lipoprotein disorders.
Schaefer EJ; Levy RI
N Engl J Med; 1985 May; 312(20):1300-10. PubMed ID: 3887163
[No Abstract] [Full Text] [Related]
35. Effects of combined probucol-colestipol treatment for familial hypercholesterolemia and coronary artery disease.
Kuo PT; Wilson AC; Kostis JB; Moreyra AE
Am J Cardiol; 1986 Jun; 57(16):43H-48H. PubMed ID: 3524177
[TBL] [Abstract][Full Text] [Related]
36. Review of clinical studies of bile acid sequestrants for lowering plasma lipid levels.
LaRosa J
Cardiology; 1989; 76 Suppl 1():55-61; discussion 61-4. PubMed ID: 2653624
[TBL] [Abstract][Full Text] [Related]
37. Combination drug therapy for familial combined hyperlipidemia.
East C; Bilheimer DW; Grundy SM
Ann Intern Med; 1988 Jul; 109(1):25-32. PubMed ID: 3288029
[TBL] [Abstract][Full Text] [Related]
38. Hypocholesterolemic effects of cholestyramine and colestipol in patients with familial defective apolipoprotein B-100.
Schmidt EB; Illingworth DR; Bacon S; Mahley RW; Weisgraber KH
Atherosclerosis; 1993 Jan; 98(2):213-7. PubMed ID: 8457260
[TBL] [Abstract][Full Text] [Related]
39. The effects of colestipol hydrochloride on serum lipoprotein lipid and apolipoprotein B and A-I concentrations in children heterozygous for familial hypercholesterolemia.
Groot PH; Dijkhuis-Stoffelsma R; Grose WF; Ambagtsheer JJ; Fernandes J
Acta Paediatr Scand; 1983 Jan; 72(1):81-5. PubMed ID: 6407278
[TBL] [Abstract][Full Text] [Related]
40. Familial Hypercholesterolaemia Regression Study: a randomised trial of low-density-lipoprotein apheresis.
Thompson GR; Maher VM; Matthews S; Kitano Y; Neuwirth C; Shortt MB; Davies G; Rees A; Mir A; Prescott RJ
Lancet; 1995 Apr; 345(8953):811-6. PubMed ID: 7898227
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
